Article

UV rays don't just damage skin

Prevent Blindness has dedicated May as UV Awareness Month in an effort to educate the public on the best way to protect their eyes.

Chicago-Ultraviolet (UV) rays, both UVA and UVB, emitted by tanning beds can cause photokeratitis. Just like sunburns to the skin, symptoms may not appear until 6 to 12 hours after exposure. Long-term UV damage to the eyes will not show up until years later.

That is why Prevent Blindness (PBA) has dedicated May as UV Awareness Month in an effort to educate the public on the best way to protect their eyes. The "Prevent Blindness America UV Learning Center" provides free information on UV, tips on purchasing the best eye protection, and a quiz to test UV knowledge.

It is required by the FDA that clean, UV-blocking goggles be provided to all consumers at all tanning facilities. Cotton balls over the eyes and sunglasses are not sufficient protection.

"We tend to think that tanned skin is glamorous or attractive, but the process is actually quite dangerous," said Daniel D. Garrett, senior vice president of PBA. "Damage from UV exposure can cause cataracts or be a factor in macular degeneration."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.